Blood testing is the primary example of this, with patients frequently required to test their own levels to stay on top of their glucose control.
Now UK sufferers can use A1CNow®, the world’s first and only disposable HbA1c system which allows healthcare professionals to provide individuals with an indicator of average blood glucose control for up to a three-month period.
The analyser is one of the first technologies to provide immediate access to A1c status, without the costly, long and complex methods other techniques use to achieve the same result.
The single-use test provides quantitative results from a single drop of blood inserted into the device. To then see their A1c status, users must insert the blood collector into the open end of the sampler body and shake, before inserting the cartridge into the device itself.
The HbA1c result will then display after just five minutes.
For people with both types of diabetes (1 and 2), understanding their HbA1c level is of utmost importance. By measuring glycated haemoglobin (HbA1c), clinicians are able to get an overall picture of what the average blood sugar levels have been over the past three months.
The higher the HbA1c, the greater the risk of developing diabetes-related complications and the necessity of catching levels early.
A recent study carried out amongst 189 diabetic and non-diabetic subjects across three US sites to test the accuracy of the device found that the portable analyser A1CNow® had an average of 99% accuracy in regards to fingerstick samples.
Further research has also found that the easy-to-use A1CNow® device meets industry leading criteria in regards to its precision.
Following precision testing done under a specialised protocol in a private laboratory, two whole blood samples of different A1C percentiles were tested over 20 days with four runs per day.
Results found that the performance of the device met with the exceptionally high standards of NGSP certification.